mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
3e-13 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-08 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-07 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-07 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-06 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-06 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |